Global Cardiac Marker Testing Market – Size, Outlook, Trends and Forecast (2024 – 2032)

A cardiac marker is a diagnostic tool, which is associated with diagnosis and risk detection in patients suffering from chest pain, acute coronary syndrome and others. Global cardiac marker testing market was valued at $2.50 billion in 2017 and is expected to reach $4.90 billion by2025 with a CAGR of 8.80% during the forecast period from 2019-2025. The factors like rapidly increasing geriatric population and the subsequent increase in the burden of heart diseases, growing funding from public–private organizations for research on cardiac biomarkers are driving the market growth. The factors like issues related to regulatory & reimbursement systems and technical problems related to sample collection and storage are hampering the market growth. Point-Of-Care testing with cardiac biomarkers and emerging markets to offer new growth avenues for market players are creating the opportunities for market growth.

Research Study Objectives:

• Define, estimate, and forecast the Cardiac Marker Testing market statistics by type, type of testing, product, diseases and regions concerning the individual growth drivers, market trends and their contribution toward the Cardiac Marker Testing market growth
• Provides comprehensive information regarding the key factors influencing the market growth (Drivers, Restraints & Challenges, and Opportunities)
• Estimate & forecast the market size of all the segments concerning geographies including North America, Europe, Asia Pacific (APAC), South America and the Middle East and Africa (MEA).
• Recent competitive developments including M&A (Mergers and Acquisitions), Partnerships, and Product Innovations are provided in the Cardiac Marker Testing Market Analysis report.
• Analysis and conclusions on the future Cardiac Marker Testing market outlook.

Top-down and bottom-up approaches are used to validate the Cardiac Marker Testing Market Size and are used to estimate the size of other dependent submarkets. Key players in the market are identified through various secondary sources; databases including Bloomberg Businessweek, Hoovers, Factiva, journals and associations and the market revenues are estimated and are thoroughly validated through primary and secondary research. Secondary research involves the study of annual and financial reports of top players in the market, whereas primary research includes extensive interviews with the KoL’s such as CEOs, directors, board members, VP’s, sales managers, engineers, marketing executives, technicians, account managers, investors, strategic decision makers and others. The Cardiac Marker Testing Market shares and breakdowns are determined using secondary sources and are verified by the primary sources. All possible parameters/factors that are affecting the Cardiac Marker Testing market demand are covered in the research study are verified through primary research, analysed and interpreted to get the final qualitative and quantitative data. This data is collected and added with detailed analysis from Envision Inteligence and presented in this report.

The scope of the Report

The Cardiac Marker Testing market segmentation is as follows:

By Type

• Bnp or Nt-Probnp
• Myoglobin
• Hscrp
• Troponin I and T
• CK-MB
• Others

By Type of Testing

• Point-Of-Care Testing
• Laboratory Testing

By Product

• Instruments
• Immunofluorescence
• Immuno chromatography
• Elisa
• Chemiluminescence
• Reagents and Kits

By Diseases

• Congestive Heart Failure
• Myocardial Infarction

Geographical Analysis:

Cardiac Marker Testing Market is segmented by geography into North America, South America, Europe, APAC and Middle East & Africa. U.S., Canada, Mexico and Costa Rica are analysed under North American region which is usually turning as the hotspot in the market. The South American region is further segregated into Brazil, Argentina, Chile, Columbia and some other emerging economies. In Europe, the market is extensively examined by covering U.K., Germany, France, Italy, Spain, Netherlands, Poland, Switzerland and some other promising economies. APAC is further categorised by countries into China, India, Japan, South Korea, Australia & New Zealand, Malaysia, Singapore and many other emerging nations. In the Middle East & African region, Saudi Arabia, UAE, Iran, Iraq, Qatar, South Africa, Algeria, Morocco, Nigeria and so on countries are evaluated to understand the market growth lucidly.

Customization Options:

With the given research report, Envision Inteligence offers customisations as per the client’s specific requirements. The following customisation options offered for the Cardiac Marker Testing Market include:

• Scope Revision
• Geographic Analysis
• Company Profiles
• Historical Data & Forecasting
• Key Contact Persons in companies

Global Cardiac Marker Testing Market Research Report Includes:

• An executive summary condensing the whole report such that essential authority can rapidly twist up doubtlessly acquainted with brief overview and conclusion.
• To have a complete market analysis through industry value chain analysis, Porter’s Five Force Model, PESTLE, SWOT analysis, and Y-o-Y analysis.
• Regional and global diversity is analysed with the major countries and the unions. Scrutinizing the revenue generation on Year-On-Year
• Identifying DROC in the current market and their impact on altering market dynamics.
• Competitive landscape analysis to identify the merger and acquisition which will have a comparative financial study with significant competitors.
• Expertise investment opportunities by an analyst to the individual and organisation to have a better foothold in the market.
• Identify the latest developments, market shares and strategies that are employed by the significant Cardiac Marker Testing market players, such as
  • Danaher Corporation
  • Biomérieux S.A.
  • Alere, Inc.
  • Mitsubishi Chemical Holdings Corporation
  • The Carlyle Group
• Along with these companies, many other companies are considered in the report while analysing the Global Cardiac Marker Testing Market competitive strategies and environment. These companies held substantial share-owning to the nature of the industry whereas, the rest of the market shares are marginal chunks to regional and local level manufacturers. Other players also have considerable presence owing to its robust brand image, geographical reach and stable customer base.